Company Overview and News

19
Fabrinet: Gearing Up For A Rebound?

2018-05-09 seekingalpha
Fabrinet (FN) reported financial results for Q3 2018 Monday and the results point to a possible boost in optical demand. The company beat on revenue and delivered in-line EPS, but guidance for Q4, which came in above consensus and indicates sequential growth in the quarter, was the catalyst that pushed the stock higher by 7.5% as I write this. I think these results might mean that FN is gearing up for a rebound.
FN ACIA

1
FN / Fabrinet FORM 10-Q (Quarterly Report)

2018-05-08 sec.gov
Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
FN

1
Fabrinet's Cash Flow Bonanza Is Underappreciated

2018-05-08 seekingalpha
Telecom revenue was up significantly for the quarter, and there are another couple of businesses that are performing well, but datacom is suffering from price erosion.
FN

1
Fabrinet 2018 Q3 - Results - Earnings Call Slides

2018-05-08 seekingalpha
The following slide deck was published by Fabrinet in conjunction with their 2018 Q3 earnings call.
FN

19
Stifel Bolsters Tech & Communications Infrastructure Coverage With Hiring of John Marchetti as Managing Director

2018-05-08 globenewswire
ST. LOUIS, May 08, 2018 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE:SF) today announced that John Marchetti has joined the firm as Managing Director and Senior Analyst covering the applied technology and communications infrastructure sector. Mr. Marchetti is based in Stifel’s New York office.
FN SF SFN MS SFB

1
Fabrinet's (FN) CEO Seamus Grady on Q3 2018 Results - Earnings Call Transcript

2018-05-08 seekingalpha
Good day, ladies and gentlemen. Welcome to Fabrinet's Financial Results Conference Call for the Third Quarter of Fiscal Year 2018. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instruction for how to participate will be given at that time. As a reminder, today's call is being recorded.
FN

1
FN / Fabrinet FORM 8-K (Current Report)

2018-05-07 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
FN

13
Fabrinet: Optical Communications Industry Underpriced Due To Unjustified Pessimistic Outlook

2018-05-07 seekingalpha
The optical communications industry continues to increase in size and demand for external manufacturing is becoming more common.
FNSR FN NPTN

99
Bulletproof Investing Performance: Week 22

2018-04-27 seekingalpha
It's been six months since I presented 3 hedged portfolios and 10 top names in week 22 of my Marketplace service (October 26th). Here's how everything did.
SQ FN GRUB CGNX ICLR IPGP NVDA NOVT

467
Buy The Dip In Lumentum Shares

2018-03-21 seekingalpha - 1
Lumentum shares jumped in the last month after markets speculated revenue acceleration from supplying for Apple's iPhone X.
FNSR AMZN FN AAOI IIVI

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to FN / Fabrinet on message board site Silicon Investor.

FNHI,,, EASY TO VERIFY FACTS,,, FNHI,,, EASY TO VERIFY FACTS,,, FNHI,,, EASY TO VERIFY FACTS,,, Finisar - FNSR Finisar - FNSR Finisar - FNSR
FNJN cyber security patent CO.no debt great potential FNJN cyber security patent CO.no debt great potential FNJN cyber security patent CO.no debt great potential No Fn WAY No Fn WAY No Fn WAY
Safenet - The Name In VPN Security (SFNT) Safenet - The Name In VPN Security (SFNT) Safenet - The Name In VPN Security (SFNT) 1st Net Technologies ( FNTT ) 1st Net Technologies ( FNTT ) 1st Net Technologies ( FNTT )
Fancamp Exploration Ltd. (FNC.V) Fancamp Exploration Ltd. (FNC.V) Fancamp Exploration Ltd. (FNC.V) XFN NTS Communications XFN NTS Communications XFN NTS Communications
Pacific North West Capital Corporation-PFN on Alberta Pacific North West Capital Corporation-PFN on Alberta Pacific North West Capital Corporation-PFN on Alberta ADVFN (AFN.L) - Advanced Financial Networks ADVFN (AFN.L) - Advanced Financial Networks ADVFN (AFN.L) - Advanced Financial Networks
CUSIP: G3323L100